Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 32
- 试验地点
- 1
- 主要终点
- Dyspnea
研究概览
简要总结
Bronchial asthma is a widespread chronic condition charactrized by inflammation and narrowing of airways, leading to repeateted episodes of breathlessness, wheezing and labored breathing.Breathing exercises help to manage hyperventilation often seen in asthmatic patients. To handle respiratory complications asthmatics are advised to practise nasal breathing techniques in conjunction with their prescribed medications.
详细描述
Bronchial asthma is a very common chronic disease marked by inflammation and constriction of airways, resulting in recurrent episodes of breathlessness, wheezing and decrease work of breathing. Breathing exercises help to manage hyperventilation associated with asthma. In order to manage respiratory conditions asthmatic patients are encouraged for nasal breathing techniques along with pharmacological management. Hence the objective of the study is to compare the effects of alternative nostril breathing along with pharmacological management versus pharmacological management alone on dyspnea, control pause, asthma control and peak expiratory flow rate in patients with bronchial asthma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults: aged (18-45 years)
- •Gender: Both males and females
- •Grade1- Grade 4 on Modified MRC dyspnea scale
- •Asthma severity classes (intermediate, mild persistent and moderate persistent asthma) acc. to NAEPP national asthma education and prevention program guidlin
排除标准
- •Patients having acute exacerbation of COPD or status asthmaticus
- •Patients diagnosed with acute infections
- •Patients unable to follow command/ instructions
- •Asthma patients with >40 sec control pause duration
- •Patients who fall in red zone of asthma action plan (PEFR < 50%)
研究组 & 干预措施
Nostril Breathing along with pharmacological therapy Group
Patients in this group will receive alternative nostril breathing along with pharmacological management.
Total 4 weeks protocol. Two sessions per week will be supervised by physiotherapist and 5 days at home. A home diary will be provided in order to ensure and follow-up that participants are performing breathing exercise at home.
干预措施: Alternative nostril breathing (Other)
Nostril Breathing along with pharmacological therapy Group
Patients in this group will receive alternative nostril breathing along with pharmacological management.
Total 4 weeks protocol. Two sessions per week will be supervised by physiotherapist and 5 days at home. A home diary will be provided in order to ensure and follow-up that participants are performing breathing exercise at home.
干预措施: Pharmacological therapy (Drug)
Pharmacological therapy Group
Patients will receive medication as prescribed by pulmonologist through stepwise approach according to symptoms and severity. Total 4 weeks protocol.
Before and after 4 weeks pre and post interventional values will be taken.
干预措施: Pharmacological therapy (Drug)
结局指标
主要结局
Dyspnea
时间窗: 4 weeks
Evaluation will be done using Dyspnea-12 questionnaire for dyspnea
Control pause
时间窗: 4 weeks
Stopwatch will be used to measure control pause.
Asthma control
时间窗: 4 weeks
Asthma control test (ACT) will be used to evaluate asthma control and peak flow meter for peak expiratory flow rate.
Peak expiratory flow rate.
时间窗: 4 Weeks
Peak flow meter will be used to measure peak expiratory flow rate
次要结局
未报告次要终点